Variant report
Variant | nsv1026831 |
---|---|
Chromosome Location | chr6:68486914-68509030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:68487636..68489959-chr6:68585344..68587572,2 | K562 | blood: | |
2 | chr6:68506908..68510214-chr6:68588930..68590665,3 | K562 | blood: | |
3 | chr6:68492831..68494635-chr6:68590295..68593150,2 | K562 | blood: | |
4 | chr6:68500812..68503276-chr6:68505426..68509268,3 | K562 | blood: | |
5 | chr6:68500812..68503514-chr6:68505426..68509054,4 | K562 | blood: | |
6 | chr6:68496731..68499262-chr6:68502770..68504642,2 | K562 | blood: | |
7 | chr6:68502919..68505150-chr6:68587246..68590550,4 | K562 | blood: | |
8 | chr6:68500812..68503514-chr6:68505426..68509054,4 | K562 | blood: | |
9 | chr6:68501174..68502825-chr6:68530814..68533551,2 | K562 | blood: | |
10 | chr6:68498733..68500691-chr6:68575961..68578214,2 | K562 | blood: | |
11 | chr6:68487893..68492102-chr6:68589175..68592601,3 | K562 | blood: | |
12 | chr6:68500812..68503276-chr6:68505426..68509268,3 | K562 | blood: | |
13 | chr6:68496731..68499262-chr6:68502770..68504642,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548386292 | chr6:68492223-68492224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187338246 | chr6:68492235-68492236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146281353 | chr6:68492241-68492242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567004934 | chr6:68492315-68492316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556938089 | chr6:68492382-68492383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369498791 | chr6:68492397-68492398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570572389 | chr6:68492402-68492403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539562019 | chr6:68492422-68492423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553504732 | chr6:68492426-68492427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139396240 | chr6:68492439-68492440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149521186 | chr6:68492445-68492446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4131870 | chr6:68492448-68492449 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs376932975 | chr6:68492520-68492521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555778398 | chr6:68492589-68492590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117282109 | chr6:68492594-68492595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192673282 | chr6:68492602-68492603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4131872 | chr6:68492620-68492621 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs4131871 | chr6:68492631-68492632 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs9294775 | chr6:68492677-68492678 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs62412319 | chr6:68492685-68492686 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs73462660 | chr6:68492700-68492701 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs144040466 | chr6:68492715-68492716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183708834 | chr6:68492735-68492736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374967828 | chr6:68492736-68492737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531510205 | chr6:68492778-68492779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369664277 | chr6:68492799-68492800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550528253 | chr6:68492816-68492817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7749517 | chr6:68492830-68492831 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs148653343 | chr6:68492844-68492845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538189931 | chr6:68492865-68492866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113887662 | chr6:68492868-68492869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112134492 | chr6:68492871-68492872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566997110 | chr6:68492899-68492900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535669228 | chr6:68492908-68492909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555933529 | chr6:68492937-68492938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376790787 | chr6:68492938-68492939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575973881 | chr6:68492949-68492950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572845442 | chr6:68492989-68492990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201971327 | chr6:68492994-68492995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201148254 | chr6:68492996-68492997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146094365 | chr6:68492999-68493000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112684307 | chr6:68493056-68493057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78617157 | chr6:68493058-68493059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539959646 | chr6:68493059-68493060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs193273343 | chr6:68493060-68493061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs558690881 | chr6:68493109-68493110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7748867 | chr6:68493133-68493134 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs573682208 | chr6:68493139-68493140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368467388 | chr6:68493206-68493207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542417010 | chr6:68493207-68493208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:68492200-68492600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr6:68492400-68492600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
3 | chr6:68492600-68494000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:68494000-68494200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:68500000-68500800 | Enhancers | Fetal Brain Male | brain |
6 | chr6:68500600-68500800 | ZNF genes & repeats | K562 | blood |
7 | chr6:68500800-68502400 | Weak transcription | K562 | blood |
8 | chr6:68502400-68503200 | Enhancers | K562 | blood |
9 | chr6:68503200-68505400 | Weak transcription | K562 | blood |
10 | chr6:68505000-68506200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr6:68505200-68506000 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr6:68505200-68506000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr6:68505200-68506000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr6:68505200-68506000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr6:68505400-68506400 | Enhancers | K562 | blood |
16 | chr6:68505600-68506000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr6:68506400-68508800 | Weak transcription | K562 | blood |
18 | chr6:68508800-68509600 | Enhancers | K562 | blood |